Iteos Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Iteos Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iteos Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iteos Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $496k | 45k | 10.95 |
| 2023-09-30 | $253k | 23k | 10.95 |
| 2023-06-30 | $592k | 45k | 13.24 |
| 2023-03-31 | $594k | 44k | 13.61 |
| 2022-12-31 | $1.8M | 91k | 19.53 |
| 2022-09-30 | $1.3M | 68k | 19.05 |
| 2022-06-30 | $3.3M | 158k | 20.60 |
| 2022-03-31 | $5.5M | 171k | 32.18 |
| 2021-12-31 | $1.8M | 38k | 46.57 |
| 2021-09-30 | $4.0k | 135 | 29.63 |
| 2021-06-30 | $74k | 2.9k | 25.66 |
| 2021-03-31 | $428k | 13k | 34.17 |
| 2020-12-31 | $122k | 3.6k | 33.83 |